UBS O'Connor’s Clarim Acquisition Corp. Class A Common Stock CLRM Stock Holding History

UBS O'Connor’s Portfolio CLRM Stock Details CLRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-474,862	Closed	-$4.7M	–	970
2022 Q3	$4.7M	Sell	474,862 -47,739	-9%	-$471K	0.05%	288
2022 Q2	$5.13M	Hold	522,601	–	–	0.05%	282
2022 Q1	$5.12M	Buy	522,601 +9,245	+2%	+$90.1K	0.06%	263
2021 Q4	$4.99M	Buy	513,356 +13,769	+3%	+$135K	0.05%	291
2021 Q3	$4.91M	Hold	499,587	–	–	0.04%	258
2021 Q2	$4.83M	Sell	499,587 -100,391	-17%	-$979K	0.04%	286
2021 Q1	$5.8M	Buy	+599,978	New	+$5.88M	0.08%	176

UBS O'Connor's CLRM Position: Q4 2022 in Review

UBS O'Connor sold out of Clarim Acquisition Corp. Class A Common Stock (CLRM) in Q4 2022, closing a stake of 474,862 shares — an estimated $4.7M sold.

UBS O'Connor first reported a position in CLRM in Q1 2021 and held it in 7 quarters. The position peaked at $5.8M in Q1 2021. 0 funds tracked by Wall St. Rank hold CLRM as of Q4 2022.

UBS O'Connor reported no remaining Clarim Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 474,862 Clarim Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $4.7M.
UBS O'Connor first reported a position in Clarim Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
UBS O'Connor's Clarim Acquisition Corp. Class A Common Stock position peaked at $5.8M in Q1 2021.
0 funds tracked by Wall St. Rank held Clarim Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.